Ambrx Biopharma Inc-adr logo

Ambrx Biopharma Inc-adr Share Price (NYSE: AMAM)

▲

-28

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 6 Mar 2024

Check the interactive Ambrx Biopharma Inc-adr Stock chart to analyse performance

Ambrx Biopharma Inc-adr Key Stats

Check Ambrx Biopharma Inc-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$28.0
Open
$27.99
Market Capitalization
$1.8B
Today's Volume
$1.4M
Revenue TTM
$4.1M
EBITDA
$-61.7M
Earnings Per Share (EPS)
$0.42
PE Ratio
66.62
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-37.23%

Global Institutional Holdings in Ambrx Biopharma Inc-adr

  • Name

    Holdings %

  • D. E. Shaw & Co LP

    44.29%

  • COMMODORE CAPITAL LP

    38.92%

  • Paradigm Biocapital Advisors LP

    38.59%

  • VR Adviser, LLC

    22.89%

  • FMR Inc

    19.48%

  • Citadel Advisors Llc

    8.50%

Analyst Recommendation on Ambrx Biopharma Inc-adr Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Ambrx Biopharma Inc-adr(by analysts ranked 0 to 5 stars)

About Ambrx Biopharma Inc-adr

Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California.
Organization
Ambrx Biopharma Inc-adr
Employees
87
CEO
Mr. Daniel J. O'Connor J.D.
Industry
Miscellaneous

Important FAQs about investing in AMAM Stock from India :

What is Ambrx Biopharma Inc-adr share price today?

Ambrx Biopharma Inc-adr share price today is as on at the close of the market. Ambrx Biopharma Inc-adr share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Ambrx Biopharma Inc-adr share?

Ambrx Biopharma Inc-adr share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Ambrx Biopharma Inc-adr stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Ambrx Biopharma Inc-adr Stock (AMAM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ambrx Biopharma Inc-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ambrx Biopharma Inc-adr Shares .

What is the minimum amount required to buy Ambrx Biopharma Inc-adr Stock (AMAM) from India?

Indian investors can start investing in Ambrx Biopharma Inc-adr (AMAM) shares with as little as ₹87.9538 or $1 (as of October 19, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Ambrx Biopharma Inc-adr stock (as per the Rupee-Dollar exchange rate as on October 19, 2025). Learn more about fractional shares .

What are the returns that Ambrx Biopharma Inc-adr has given to Indian investors in the last 5 years?

Ambrx Biopharma Inc-adr stock has given 0.0% share price returns and 19.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?